RSGK Stock Overview

Owns and operates hospitals in Indonesia. More details

RSGK fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	4/6
Financial Health	6/6
Dividends	2/6

Rewards

Price-To-Earnings ratio (23.1x) is below the Healthcare industry average (35.9x)

Earnings grew by 66.5% over the past year

Risk Analysis

Earnings have declined by 1.2% per year over past 5 years

Does not have a meaningful market cap (IDR934B)

Volatile share price over the past 3 months compared to the ID market

Dividend of 2.19% is not well covered by free cash flows

My Notes

Capture your thoughts, links and company narrative

PT Kedoya Adyaraya Tbk Competitors

Bundamedik

IDX:BMHS

Rp2.1t

Famon Awal Bros Sedaya

IDX:PRAY

Rp8.8t

Medikaloka Hermina

IDX:HEAL

Rp21.1t

Mitra Keluarga Karyasehat

IDX:MIKA

Rp32.3t

Price History & Performance

Summary of share price highs, lows and changes for Kedoya Adyaraya
Historical stock prices
Current Share Price	Rp1,005.00
52 Week High	Rp1,425.00
52 Week Low	Rp795.00
Beta	0.17
1 Month Change	-20.87%
3 Month Change	-19.92%
1 Year Change	-19.28%
3 Year Change	-41.06%
5 Year Change	n/a
Change since IPO	-53.26%

Recent updates

Shareholder Returns

	RSGK	ID Healthcare	ID Market
7D	-2.4%	-2.4%	-3.6%
1Y	-19.3%	17.4%	2.7%

Return vs Industry: RSGK underperformed the ID Healthcare industry which returned 17.3% over the past year.

Return vs Market: RSGK underperformed the ID Market which returned 2.7% over the past year.

Price Volatility

Is RSGK's price volatile compared to industry and market?
RSGK volatility
RSGK Average Weekly Movement	8.9%
Healthcare Industry Average Movement	5.5%
Market Average Movement	5.5%
10% most volatile stocks in ID Market	12.8%
10% least volatile stocks in ID Market	2.4%

Stable Share Price: RSGK's share price has been volatile over the past 3 months compared to the ID market.

Volatility Over Time: RSGK's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of ID stocks.

About the Company

Founded	Employees	CEO	Website
1990	711	Liem Hong	www.grhahospitals.com

PT Kedoya Adyaraya Tbk owns and operates hospitals in Indonesia. The company provides facilities, such as inpatient and outpatient room, operating room, delivery room, HCU, ICU, ICCU, PICU, NICU, emergency room, inpatient, outpatient, covid ICU isolation, endoscopy, operating room, sterilization service center installation, and delivery room. It also offers medical support services, including pharmacy, radiology, CT-Scan, mammography, mobile x-ray, general x-ray, 4D ultrasound, central sterile supply department, fluoroscopy unit, mobile C-Arm, bone densitometry, laparoscopy, bronchoscopy, catheterization laboratory, spirometry, audiometry, electroencephalography, electromyography, electrocardiogram, treadmill, echocardiography, hemodialysis, laser treatment, medical rehabilitation, trauma center, nutrition unit, medical record, panoramic, cephalometry, digital radiography, 4D USG, and 2D/3D USG, as well as laboratories for chemistry, hematology, hemostasis, microbiology, immune-serology, and biomolecular.

PT Kedoya Adyaraya Tbk Fundamentals Summary

How do Kedoya Adyaraya's earnings and revenue compare to its market cap?
RSGK fundamental statistics
Market cap	Rp934.32b
Earnings (TTM)	Rp40.39b
Revenue (TTM)	Rp435.76b

23.1x

P/E Ratio

2.1x

P/S Ratio

Is RSGK overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RSGK income statement (TTM)
Revenue	Rp435.76b
Cost of Revenue	Rp275.24b
Gross Profit	Rp160.53b
Other Expenses	Rp120.14b
Earnings	Rp40.39b

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	43.45
Gross Margin	36.84%
Net Profit Margin	9.27%
Debt/Equity Ratio	0%

How did RSGK perform over the long term?

See historical performance and comparison

Dividends

2.2%

Current Dividend Yield

25%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 04:03
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PT Kedoya Adyaraya Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution